Bioengineered arginase i increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1

Surgery

Volumn 148, Issue 2, 2010, Pages 310-318

  Glazer, Evan S ^a   Kaluarachchi, Warna D ^a   Massey, Katheryn L ^a   Zhu, Cihui ^a   Curley, Steven A ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARGINASE 1; ARGININOSUCCINATE SYNTHASE; ARGININOSUCCINATE SYNTHASE 1; CASPASE 3; COBALT; KI 67 ANTIGEN; UNCLASSIFIED DRUG; ARGINASE; ARGININE; CASP3 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ENGINEERING; ENZYME INDUCTION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; NITROBLUE TETRAZOLIUM TEST; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STUDENT T TEST; WESTERN BLOTTING; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECT; ENZYMOLOGY; LIVER TUMOR; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; PROTEIN ENGINEERING; TUMOR CELL LINE;

APOPTOSIS; ARGINASE; ARGININE; ARGININOSUCCINATE SYNTHASE; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME INDUCTION; HUMANS; KI-67 ANTIGEN; LIVER NEOPLASMS; MODELS, BIOLOGICAL; PANCREATIC NEOPLASMS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 77955300014     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.03.022     Document Type: Article

References (22)

1. B.J. Dillon, V.G. Prieto, S.A. Curley, C.M. Ensor, F.W. Holtsberg, and J.S. Bomalaski Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation Cancer 100 2004 826 833
2. P.N. Cheng, T.L. Lam, W.M. Lam, S.M. Tsui, A.W. Cheng, and W.H. Lo Pegylated recombinant human arginase (rhArg-peg(5,000mw)) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion Cancer Res 67 2007 309 317
3. S.A. Curley, J.S. Bomalaski, C.M. Ensor, F.W. Holtsberg, and M.A. Clark Regression of hepatocellular cancer in a patient treated with arginine deiminase Hepato-Gastroenterol 50 2003 1214 1216
4. L. Feun, M. You, C.J. Wu, M.T. Kuo, M. Wangpaichitr, and S. Spector Arginine deprivation as a targeted therapy for cancer Curr Pharm Des 14 2008 1049 1057
5. T.L. Bowles, R. Kim, J. Galante, C.M. Parsons, S. Virudachalam, and H.J. Kung Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase Int J Cancer 123 2008 1950 1955
6. A. Barbul Arginine and immune function Nutrition 108 1990 653 658
7. C.Y. Yoon, Y.J. Shim, E.H. Kim, J.H. Lee, N.H. Won, and J.H. Kim Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase Int J Cancer 120 2007 897 905
8. K. Miyazaki, H. Takaku, M. Umeda, T. Fujita, W.D. Huang, and T. Kimura Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line Cancer Res 50 1990 4522 4527
9. F. Izzo, P. Marra, G. Beneduce, G. Castello, P. Vallone, and V. De Rosa Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma. Results from phase I/II studies J Clin Oncol 22 2004 1815 1822
10. E.S. Glazer, M. Piccirillo, V. Albino, R. Di Giacomo, R. Palaia, and A.A. Mastro Phase II study of pegylated arginine deiminase for non-resectable and metastatic hepatocellular carcinoma J Clin Oncol 2010 Mar 29 [Epub ahead of print]
11. P.A. Dinndorf, J. Gootenberg, M.H. Cohen, P. Keegan, and R. Pazdur FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL) Oncologist 12 2007 991 998
12. R. Junowicz-Kocholaty, and W. Kocholaty Arginase. Science 94 2432 1941 144
13. O. Shi, D. Kepka-Lenhart, S.M. Morris Jr., and W.E. O'Brien Structure of the murine arginase II gene Mamm Genome 9 1998 822 824
14. P.N. Cheng, Y.C. Leung, W.H. Lo, S.M. Tsui, and K.C. Lam Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma Cancer Lett 22 2005 467 480
15. E.M. Stone, E.S. Glazer, L. Chantranupong, P. Cherukuri, R.M. Breece, and D.L. Tierney Replacing Mn2+ with Co2+ in human arginase I enhances cytotoxicity towards L-arginine auxotrophic cancer cell lines ACS Chemical Biol 19 2010 333 342
16. Assay Guidance Manual, Version 5.0. Eli Lilly and Company and NIH Chemical Genomics Center.
17. Y.H. Chen, I.J. Wang, and T.H. Young Formation of keratocyte spheroids on chitosan-coated surface can maintain keratocyte phenotypes Tissue Eng Part A 15 2009 2001 2013
18. K.S. Smalley, R. Contractor, N.K. Haass, J.T. Lee, K.L. Nathanson, and C.A. Medina Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels Br J Cancer 96 2007 445 449
19. S. Al-Nasiry, B. Spitz, M. Hanssens, C. Luyten, and R. Pijnenborg Differential effects of inducers of syncytialization and apoptosis on BeWo and JEG-3 choriocarcinoma cells Hum Reprod 21 2006 193 201
20. G. Koopman, C.P. Reutelingsperger, G.A. Kuijten, R.M. Keehnen, S.T. Pals, and M.H. van Oers Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 84 1994 1415 1420
21. W. Gorczyca, J. Gong, and Z. Darzynkiewicz Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays Cancer Res 53 1993 1945 1951 (Pubitemid 23127129)
22. R.H. Kim, R.J. Bold, and H.J. Kung ADI, autophagy and apoptosis Metabolic stress as a therapeutic option for prostate cancer Autophagy 5 2009 567 568